The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Letter to the editor
Editor, – As an eye surgeon I was surprised to read that warfarin was contraindicated when eye surgery was contemplated (Aust Prescr 2004;27:88-92). Given that cataract surgery is one of the most common elective surgical procedures performed in this country and most patients are aged over 65, this advice was somewhat at odds with accepted practice. A number of papers have looked at this issue and a study from New Zealand suggested that there was no greater risk of adverse events in patients undergoing surgery being maintained on warfarin, provided their INR was between 2.0 and 2.5.1
Mount Gambier, SA
- Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 2000;28:419-22.
- Kearon C, Hirsch J. Management of anticoagulation